Skip to main content
Clinical Trials/NCT01010763
NCT01010763CompletedNot Applicable

A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty

Zimmer Biomet1 site in 1 country184 target enrollmentStarted: November 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
184
Locations
1
Primary Endpoint
Range of Motion

Study Overview

Brief Summary

The purpose of this study includes the investigation of Metal-ion release and Renal Function analysis in M2a Total Hip Arthroplasty.

Detailed Description

There are no clinical studies conducted on its performance in Asian population. Furthermore clinical data is required to support marketing and validate design of M2A Magnum.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients suitable for primary Total Hip Replacement
  • •Patients aged over 20
  • •Patients with limited co-morbidity- ASA I-III
  • •Patients must be able to understand instructions and be willing to return for follow-up
  • •Patients willing to provide blood and urine samples for metal ion analysis at follow-up

Exclusion Criteria

  • •Pre-existing metal implants
  • •Infection, sepsis, and osteomyelitis
  • •Uncooperative patient or pt with neurologic disorders who are incapable of following directions
  • •Osteoporosis
  • •Metabolic disorders which may impair bone formation
  • •osteomalacia
  • •distant foci of infections which may spread to the implant site
  • •rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
  • •vascular insufficiency, muscular atrophy, or neuromuscular disease
  • •pregnancy

Arms & Interventions

M2a Magnum

Experimental

Total HIp Arthroplasty using with the M2a Magnum Large Metal Articulation is an ultra-high performance metal-on-metal articulation with a big ball (greater than or equal to 38mm) in acetabulums as small as 44mm.

Intervention: Total Hip Arthroplasty (Device)

M2a Taper

Active Comparator

Total Hip Arthroplasty using with the M2a Taper Acetabular System consists of a titanium outer shell with cobalt chromium (Co-Cr-Mo) metallic liner, which articulates with with a cobalt chromium (Co-Cr-Mo) modular femoral head.

Intervention: Total Hip Arthroplasty (Device)

Outcomes

Primary Outcomes

Range of Motion

Time Frame: 1 year

Hip Flexion Angle at 1 year postoperatively

Secondary Outcomes

  • Metal Ion(5 year)
  • UCLA Activity Score(5 year)
  • Radiographic Assessment(5 year)
  • Harris Hip Score(5 year)
  • Metal Ion(3 month)
  • Metal Ion(6 month)
  • Metal Ion(1 year)
  • Metal Ion(2 year)
  • Metal Ion(3 year)
  • Metal Ion(4 year)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials